Literature DB >> 1975007

Vigabatrin and behaviour disturbances.

M K Robinson, A Richens, R Oxley.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 1975007     DOI: 10.1016/0140-6736(90)92051-i

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

2.  Rapid aggravation of aphasia by vigabatrin.

Authors:  R Gil; J P Neau
Journal:  J Neurol       Date:  1995-03       Impact factor: 4.849

Review 3.  Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.

Authors:  S M Grant; R C Heel
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 4.  CNS adverse events associated with antiepileptic drugs.

Authors:  Gina M Kennedy; Samden D Lhatoo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 5.  Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review.

Authors:  Martin J Brodie; Frank Besag; Alan B Ettinger; Marco Mula; Gabriella Gobbi; Stefano Comai; Albert P Aldenkamp; Bernhard J Steinhoff
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 6.  Behavioural effects of the new anticonvulsants.

Authors:  F M Besag
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.